期刊文献+

伴少量新月体形成IgA肾病重复肾活检资料分析 被引量:1

Clinicopathological Analysis for Repeated Renal Biopsy in Patients with IgA Nephropathy with Partial Crescentic Formation
下载PDF
导出
摘要 目的探讨免疫抑制剂治疗伴少量新月体形成的IgA肾病的疗效。方法回顾性分析伴新月体形成的IgA肾病患者免疫抑制治疗前后两次肾活检时临床和病理资料。结果24例IgA肾病患者首次肾活检时发现均伴有细胞性新月体,均接受免疫抑制治疗,未发现严重不良反应。两次肾活检时血压、肌酐和肾小球滤过率差异无统计学意义。重复活检时血红蛋白和白蛋白上升(P均<0.05)。24h尿蛋白定量明显减少(P=0.000)。两次肾活检系膜区IgA、C3荧光强度比较,差异无统计学意义。重复活检时肾小球系膜细胞增生明显减轻,但球性硬化肾小球比例升高,肾小管间质纤维化明显加重。尽管两次肾活检细胞性新月体比例比较,差异无统计学意义,但有降低趋势。其中有12例患者在第2次肾活检时细胞性新月体完全消失。节段硬化、球囊粘连和间质炎性细胞浸润比较,差异无统计学意义。结论IgA肾病即使伴少量细胞性新月体形成也要尽早干预。免疫抑制治疗在短期内能明显减少尿蛋白、稳定肾功能、改善贫血和减轻肾脏急性病变。最佳的治疗方案仍有待于明确。必要时还要重复肾活检调整治疗方案。 Objective To investigate the efficacy of immunosuppressive agents in the treatment of IgA nephropathy with a small amount of crescentic formation.Methods Clinical and pathological data of IgA nephropathy patients with partial crescent formation who received repeat renal biopsies were retrospectively analyzed in our kidney division.Results Cellular crescent bodies were found in 24 IgA nephropathy patients at the first renal biopsy.All patients received immunosuppressive therapy without serious adverse reactions.There was no significant difference in blood pressure,creatinine and glomerular filtration rate between two renal biopsies.At the second biopsy,the hemoglobin and albumin increased.24-h urinary protein excretion decreased significantly.There was no significant difference in the fluorescence intensity of IgA and C3 between two renal biopsies.The mesangial cell proliferation were decreased significantly,but the proportion of global glomerulosclerosis and tubulointerstitial fibrosis were significantly increased.Although there was no statistical significance in the proportion of glomerular crescent formation between two renal biopsies,there was a decrease tendency,even completely disappeared in 12 patients disappeared during second renal biopsy.There was no significant difference in segmental sclerosis,balloon adhesion and interstitial inflammatory cell infiltration.Conclusion Early intervention is necessary even IgA nephropathy with partial cellular crescent formation.The immunosuppressive therapy of IgA nephropathy with partial cellular crescent can obviously reduce proteinuria,stabilize renal function,improve anemia and reduce acute kidney injury without overt adverse effects in a short-term follow-up.However,there is still a chronic progress trend.The optimal treatment remains to be clarified.Repeat renal biopsy is conducted if necessary.
作者 罗勉娜 黄志清 李尚妹 许勇芝 刘华锋 Luo Mianna;Huang Zhiqing;Li Shangmei(Institute of Nephrology,Guangdong Medical University,Guangdong 524001,China)
出处 《医学研究杂志》 2019年第5期130-133,共4页 Journal of Medical Research
基金 广东医科大学省市共建重点项目(2017年) 广东省湛江市科技招标项目(2016A307,2014A01018)
关键词 IGA肾病 新月体 重复肾活检 免疫抑制治疗 肾脏病理 IgA nephropathy Crescent Repeated renal biopsy Immunosuppressive treatment Renal pathology
  • 相关文献

参考文献3

二级参考文献54

  • 1姚勇,刘景城,肖慧捷,黄建萍,杨霁云.伴有新月体形成的原发性IgA肾病的临床与病理分析[J].中华儿科杂志,2004,42(6):412-416. 被引量:20
  • 2陈香美,谢院生.重视延缓IgA肾病进展的基础和临床研究[J].中华肾脏病杂志,2004,20(4):235-237. 被引量:155
  • 3鲍浩,黎磊石,刘志红,孙骅,张馨,陈惠萍,曾彩虹,郑春霞.不同类型IgA肾病的临床病理比较[J].肾脏病与透析肾移植杂志,2006,15(5):409-415. 被引量:35
  • 4Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol, 2005, 18: 503-512.
  • 5Aruga S, Horiuchi T, Shou L, et al. Relationship between renal anemia and prognostic stages of IgA nephropathy. J Clin Lab Anal, 2005, 19: 80-83.
  • 6Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis, 1999, 34: 125-134.
  • 7IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis, 2001, 37(1 Suppl 1): S182-$238.
  • 8Gao J, Cui J, Wang Y, et al. Identification of potential predictors for subtype IgA nephropathy through analyses of blood biochemical indicators. Clin Chim Acta, 2011, 412: 441-445.
  • 9Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropnietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol, 1992, 12: 5447-5454.
  • 10Wang GL, Semenza GL. General involvement of hypoxia- inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA, 1993, 90: 4304-4308.

共引文献27

同被引文献12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部